Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
4.660
-0.010 (-0.21%)
At close: Apr 10, 2026, 4:00 PM EDT
4.300
-0.360 (-7.73%)
After-hours: Apr 10, 2026, 7:18 PM EDT
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of $55.26 million as of April 10, 2026. Its market cap has increased by 30.07% in one year.
Market Cap
55.26M
Enterprise Value
29.49M
1-Year Change
30.07%
Ranking
Category
Stock Price
$4.66
Market Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from $72.85M to $55.26M, a decrease of -24.15%. That is a compound annual growth rate of -6.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 52.63M | -10.95% |
| Dec 31, 2025 | 59.10M | 81.41% |
| Dec 31, 2024 | 32.58M | 73.79% |
| Dec 29, 2023 | 18.75M | -20.04% |
| Dec 30, 2022 | 23.45M | -67.78% |
| Dec 31, 2021 | 72.76M | -0.12% |
| Nov 25, 2021 | 72.85M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kezar Life Sciences | 54.48M |
| Edesa Biotech | 53.76M |
| ImageneBio | 53.13M |
| Mereo BioPharma Group | 52.16M |
| OS Therapies | 51.71M |
| Grace Therapeutics | 51.53M |
| PDS Biotechnology | 51.24M |
| Metagenomi Therapeutics | 51.16M |